Google partners with psychiatric drug front group to push mental illness “self diagnosis” tool that will generate more profits for Big Pharma

Pharmaceutical companies are becoming increasingly greedy and conniving when it comes to recruiting new victims for their drug offerings, as evidenced by a new online tool being released by search engine giant Google. Known as “Dr. Google,” the deceptive program is the brainchild of the National Alliance on Mental Illness (NAMI), a pro-psychiatric drug front group that wants more people to believe that they suffer from mental illnesses that require interventions with mind-altering psychiatric medications.

According to reports, users will be able to log onto Dr. Google and take a nine-step “quiz” that will assess whether or not they suffer from mental illness. Available only to Google users in the United States, which are apparently the perfect targets due to lax American drug advertising laws, Dr. Google claims to be able to determine whether or not a person is sick in the head based on just a few generic answers, to which users will be advised for further treatment.

How do users find Dr. Google, you might be asking yourself? They don’t, technically. It automatically pops up in the ‘knowledge panel” on the right-hand side of the screen when American users search for the term “depression.” In other words, potential sufferers of clinical depression are targeted based on their search queries with a crafty form of drug advertising that’s speciously disguised as an online quiz – because who doesn’t like a quiz; they’re fun, right?

In essence, Dr. Google is designed to pop up on the screen as a quiz with the words, “check if you’re clinically depressed.” Curious users will click it, take the quiz, and nine times out of ten be told that they’re mentally ill and in need of a drug-based intervention. These same users will then presumably call their doctors to make an appointment for a drug evaluation, just as Big Pharma intends.

“More than 16 million Americans – 7 percent of the country – suffer from some form of depression, with that rate steadily climbing,” one report claims, apparently in support of this latest psychological affront on Americans by the drug industry. “And yet, studies show it takes around six years for a person to be diagnosed with the mental illness, and only 50 percent of sufferers receive treatment.”

Facebook and Instagram to launch their own mental illness ‘detectors’ to further fill drug company coffers with cash

Some of the questions included in the quiz include things like “Over the past 2 weeks, how often have you been bothered by the following problem?” followed by, “Little interest or pleasure in doing things.” Among the multiple-choice answers are “Not at all,” “Several says,” “More than half the days,” and “Nearly every day.”

Both the question and the answers are intentionally vague so as to rally as many people behind the idea that they must be mentally ill if they don’t feel in tip-top shape on a daily basis. Nevermind all the calamitous world events politically, socially, and even those related to the climate – if you’re feeling bad, it must be because you’re suffering from a deficiency in antidepressant drugs like selective serotonin reuptake inhibitors (SSRIs).

That’s the goal, after all: To sign as many people up for SSRIs as is possible to further enrich Big Pharma at the expense of the public’s sanity. Anyone who’s looked into SSRIs independent of what the drug-pushers claim about their alleged worth already knows that SSRIs don’t exactly work and are far from safe.

But that isn’t stopping Google and other technocratic organizations from partnering with Big Pharma to push them on the populace. Even Facebook and Instagram are reportedly getting involved, as both companies are planning to release their own antidepressant quiz modules in the very near future. Every possible platform that people use to communicate with one another or access news will apparently be littered with this pro-drug propaganda, and the NAMI is very proud of the direction this endeavor is going.

“We believe that awareness of depression can help empower and educate you, enabling quicker access to treatment,” NAMI CEO Mary Giliberti is quoted as saying, spinning the true purpose of these pro-drug modules, which is to greatly increase revenues for pharmaceutical companies at the expense of public health.

Google claims that part of the reason why it decided to partner with NAMI, despite the obvious financial windfall that it stands to bring in, is that an increasing number of people are searching for words like “suicide” and “how to commit suicide.” A recent report by San Diego University attributes this increase to a television show on Netflix entitled “13 Reasons Why,” which tells the story of a suicidal teenage girl. In the 19 days following the show’s release, there was reportedly 1.5 million more suicide-related searches on Google than prior to its release, especially as the show has been accused of “glamorizing” suicide.

Sources for this article include:

DailyMail.co.uk

NaturalNews.com